Five-Year Survival Results of Subcutaneous Low-Dose Immunotherapy with Interleukin-2 Alone in Metastatic Renal Cell Cancer Patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Five-Year Survival Results of Subcutaneous Low-Dose Immunotherapy with Interleukin-2 Alone in Metastatic Renal Cell Cancer Patients

Published:2000 Issue:1 Volume:64 Page:3-8
ISSN:0042-1138
Container-title:Urologia Internationalis
language:en
Short-container-title:Urol Int

Author:

Bordin Veronica,Giani Luisa,Meregalli Sofia,Bukovec Roberta,Vaghi Massimo Maria,Mandalà Mario,Paolorossi Franco,Ardizzoia Antonio,Tancini Gabriele,Barni Sandro,Frigerio Franco,Fumagalli Luca,Bordoni Arrigo,Valsuani Gianni,Di Felice Greta,Lissoni Paolo

Publisher

S. Karger AG

Subject

Urology

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interleukin-2 and Interferon-α for Advanced Renal Cell Carcinoma: Patient Outcomes, Sexual Dimorphism of Responses, and Multimodal Treatment Approaches over a 30-Year Period;Urologia Internationalis;2022

2. Generalization of information substantiating the method of subcutaneous administration of recombinant human interleukin-2;Terapevt (General Physician);2021-10-16

3. Maintenance therapy in solid tumors;Community Oncology;2012-08

4. Sorafenib for the treatment of renal cancer;Expert Opinion on Pharmacotherapy;2012-01-20

5. Changes in Lymphocyte Count Induced by Repeated Cycles with Low-Dose Interleukin-2 and Interferon-α in 146 Patients with Renal Cell Carcinoma;Tumori Journal;2012-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP